A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

NCT05796245 · clinicaltrials.gov ↗

COMPLETED

Status

2207

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid
Colitis, Ulcerative
Crohn Disease
Psoriasis

Sponsor

Pfizer